Key facts
- This page summarizes Pillar Invest Corp's Form 3/A - Amendment filing for Aceragen, Inc..
- 0 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 19 Jul 2023, 16:05.
Pillar Invest Corp - 16 May 2023 Form 3/A - Amendment Insider Report for Aceragen, Inc.
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- N/A
- Reported as of
- 16 May 2023
- Net transaction value
- $0
- SEC form
- 3/A - Amendment
- Accepted by SEC
- 19 Jul 2023, 16:05:07 UTC
- Original report date
- 23 Jun 2023
- Prior SEC filing
- 26 Sep 2022
- Next SEC filing
- 19 Jul 2023
- Source filing
- View source filing
- Reporting owner signature
- Pillar Invest Corporation, /s/ Youssef El Zein, Authorized Person
Source evidence
Original filing metadata and source links for verification.
6 source fields
Reporting owner
1 detail
Key filing fact
Pillar Invest Corp filed Form 3/A - Amendment for Aceragen, Inc. on 19 Jul 2023.
Change
- Previous filing in this sequence was filed on 26 Sep 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3/A - Amendment disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ACGN
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 355,247
- Date
- 16 May 2023
- Ownership
- By Pillar Partners Foundation, L.P.
- Footnotes
- F1
ACGN
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 135,540
- Date
- 16 May 2023
- Ownership
- By Pillar Pharmaceuticals 6, L.P.
- Footnotes
- F1
ACGN
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 143,747
- Date
- 16 May 2023
- Ownership
- By Abude Umari
- Footnotes
- F1
ACGN
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,547
- Date
- 16 May 2023
- Ownership
- By Youssef El Zein
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ACGN
holding
Derivative
Warrants
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 16 May 2023
- Ownership
- By Pillar Partners Foundation, L.P.
- Underlying class
- Common Stock
- Underlying amount
- 162,601
- Exercise price
- $0.0100
- Footnotes
- F1, F2
ACGN
holding
Derivative
Warrants
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 16 May 2023
- Ownership
- By Pillar Partners Foundation, L.P.
- Underlying class
- Common Stock
- Underlying amount
- 35,687
- Exercise price
- $0.0100
- Footnotes
- F1, F2
ACGN
holding
Derivative
Warrants
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 16 May 2023
- Ownership
- By Pillar Pharmaceuticals 6, L.P.
- Underlying class
- Common Stock
- Underlying amount
- 45,114
- Exercise price
- $0.0100
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Pillar Invest Corporation ("Pillar GP") is the general partner of Pillar Pharmaceuticals 6, L.P. ("Pillar 6") and Pillar Partners Foundation, L.P. ("Pillar Partners", together with Pillar GP and Pillar 6, the "Pillar Funds"). Youssef El Zein and Abude Umari are directors of Pillar GP. Each of Pillar GP, Mr. El Zein and Mr. Umari disclaims Section 16 beneficial ownership of the securities beneficially owned by the Pillar Funds and this report shall not be deemed an admission that any of Pillar GP, Mr. El Zein or Mr. Umari is the Section 16 beneficial owner of any such securities, except to the extent of its or his pecuniary interest therein, if any, by virtue of its or his ownership interest in the Pillar Funds or Pillar GP, as applicable.
Footnote F2
The warrants are exercisable subject to a beneficial ownership blocker provision that prevents the holder from exercising the warrants if such exercise would result in the holder beneficially owning more than 19.99% of the Issuer's Common Stock outstanding following such exercise.
SEC remarks
This Amendment on Form 3/A amends and restates the Form 3 originally filed on June 23, 2023 in its entirety for the sole purpose of excluding 29,965 shares of the Issuer's Common Stock purchased on May 17, 2023 by Mr. Umari, which were previously inadvertently reported in the Form 3 filing and will instead be included in a Form 4 filing.